Montelin, Myca .
HRN: 24-08-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2023
CEFUROXIME 750MG (VIAL)
11/12/2023
11/19/2023
IV
240mg
Q8H
Benign Febrile Seizure; PCAP B
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes